Skip to content
logo with text
  • What we do
    • Scouting and Out-Licensing
    • Consulting to BD&L
    • Training
  • Current Projects
    • Topical Candidate for Eczema and Related Conditions
    • Custom Nanocomplex Formulation Opportunities
  • About Us
  • Contact
Menu
  • What we do
    • Scouting and Out-Licensing
    • Consulting to BD&L
    • Training
  • Current Projects
    • Topical Candidate for Eczema and Related Conditions
    • Custom Nanocomplex Formulation Opportunities
  • About Us
  • Contact
Read more about the article Coronavirus: Where to Begin?

Coronavirus: Where to Begin?

  • Post author:Carlos
  • Post published:March 6, 2020
  • Post category:Conferences/Drug Development/Government
  • Post comments:0 Comments

It is an interesting question. With so much information and mis-information coming at us, it is difficult to tackle this issue in a meaningful and insightful way. For those of you who are statistically…

Continue ReadingCoronavirus: Where to Begin?
Read more about the article How to get the most out of partnering conferences

How to get the most out of partnering conferences

  • Post author:Carlos
  • Post published:November 26, 2019
  • Post category:Conferences
  • Post comments:0 Comments

Like you, we go to a lot of partnering conferences...BIO...BIO-Europe...BioTrinity...and so on.  But these conferences are expensive, time consuming, and exhausting.  So...how can we get the most value from these…

Continue ReadingHow to get the most out of partnering conferences
Read more about the article What is confidential? – The FAQ Edition

What is confidential? – The FAQ Edition

  • Post author:Carlos
  • Post published:July 24, 2019
  • Post category:Business Development/Licensing/Conferences
  • Post comments:0 Comments

Our recent post entitled “What is confidential?” triggered a few questions and comments via email. Our latest post tackles these questions.

Continue ReadingWhat is confidential? – The FAQ Edition
Read more about the article What is confidential?

What is confidential?

  • Post author:Carlos
  • Post published:July 15, 2019
  • Post category:Business Development/Licensing/Conferences
  • Post comments:0 Comments

What is confidential? And what should you disclose before and after a CDA is signed?

Continue ReadingWhat is confidential?
Read more about the article Sponsorship Opportunity – The Third Annual Lacerta Bio Pre-BIO2020 Primer

Sponsorship Opportunity – The Third Annual Lacerta Bio Pre-BIO2020 Primer

  • Post author:Carlos
  • Post published:June 19, 2019
  • Post category:Conferences
  • Post comments:0 Comments

Want to meet more prospective clients and investors at #BIO2020? Lacerta BIO is offering you the opportunity to sponsor your own event in San Diego.

Continue ReadingSponsorship Opportunity – The Third Annual Lacerta Bio Pre-BIO2020 Primer

Can AI Revolutionize Business Development?

  • Post author:Carlos
  • Post published:October 1, 2018
  • Post category:Business Development/Licensing/Conferences
  • Post comments:0 Comments

Want to spend an entire decade surfing the web?  Try finding and reading every article on “artificial intelligence.”  A serious branch of computer science has rapidly turned into a buzzword…

Continue ReadingCan AI Revolutionize Business Development?

Time for the #BIO2018 Follow Up Blues

  • Post author:Carlos
  • Post published:June 10, 2018
  • Post category:Conferences
  • Post comments:0 Comments

Conferences like #BIO2018 are challenging, but highly rewarding experiences. This year was especially good, thanks to the record-setting crowd that attended the event in Boston.  Conferences are a unique way…

Continue ReadingTime for the #BIO2018 Follow Up Blues

#BIOEuropeSpring: Muscles, Meetings, and Mustard

  • Post author:Carlos
  • Post published:March 17, 2018
  • Post category:Business Development/Licensing/Conferences
  • Post comments:0 Comments

  Last week was another jam-packed week of meetings, this time at BIO-Europe Spring in Amsterdam. It is only our third appearance at this event, having participated in previous BIO…

Continue Reading#BIOEuropeSpring: Muscles, Meetings, and Mustard

Only 100 Days Until #BIOEurope Spring…

  • Post author:Carlos
  • Post published:November 28, 2017
  • Post category:Conferences
  • Post comments:0 Comments

  As of this writing, there are 100 days until we're wheels up and on our way to BIOEurope Spring in Amsterdam. Many believe it is too soon to think…

Continue ReadingOnly 100 Days Until #BIOEurope Spring…

#BIOEurope: Schnell und Hektisch

  • Post author:Carlos
  • Post published:November 12, 2017
  • Post category:Conferences
  • Post comments:0 Comments

  It's amazing how months of preparation for a conference are realized in 4-5 intense days.  From Sunday afternoon until the wee hours of Thursday morning, BIO-Europe in Berlin was…

Continue Reading#BIOEurope: Schnell und Hektisch
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 8
  • Go to the next page

Recent Posts

  • GIGO: AI and Drug Candidate Valuation – Part V
  • The Platform Question: AI and Drug Candidate Valuation – Part IV
  • On Getting pAId: AI and Drug Candidate Valuation – Part III
  • Children And Crayons: AI and Drug Candidate Valuation – Part II
  • Clowns on a Stage

Archives

  • March 2026
  • February 2026
  • January 2026
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • June 2025
  • December 2024
  • October 2024
  • September 2024
  • April 2024
  • May 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • June 2022
  • March 2022
  • June 2021
  • February 2021
  • December 2020
  • September 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • July 2019
  • June 2019
  • May 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • May 2014
  • April 2014
  • February 2014
  • January 2014
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010

Categories

  • Artificial Intelligence
  • BD&L
  • Biosimilars
  • Biotech
  • Business Development/Licensing
  • China
  • Conferences
  • COVID-19
  • CRO
  • Diagnostics
  • Digital Health
  • Digital Medicine
  • Downsizing
  • Drug Delivery
  • Drug Development
  • Drug Discovery
  • Due Diligence
  • Emerging Markets
  • Entrepreneurship
  • Europe
  • Financing
  • Generics
  • Government
  • India
  • Marketing
  • Mergers & Acquisitions
  • Offshoring
  • Outsourcing
  • Pharmaceutical
  • Planning
  • Pricing
  • Reimbursement
  • Social Media
  • Tech Transfer
  • Uncategorized
  • Venture Capital

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Get in touch

To contact us, please email us at mail: info@lacertabio.com to schedule your free consultation, or call tele:+1 (845) 293-3343.